ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1465

Follicular Helper T Cells Control Autoimmunity through IL-21/IL-21 Receptor Interaction in RA Patients

Shikha Singla1, Minzi Chen2, Jerry Pounds Jr.2, Omar Khan2, Jerald M. Zakem2, Kismet Collins2, Tamika Webb-Detiege2, William E. Davis2, Robert Quinet2 and Xin Zhang3, 1Rheumatology, Ochner Medical Center, New Orleans, LA, 2Rheumatology, Ochsner Medical Center, New Orleans, LA, 3Institute of Translational Research, Ochsner Medical Center, New Orleans, LA

Meeting: 2014 ACR/ARHP Annual Meeting

Keywords: ACPA, cytokines and rheumatoid arthritis (RA), T cells

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Human Etiology and Pathogenesis

Session Type: Abstract Submissions (ACR)

Background/Purpose Rheumatoid Arthritis (RA) is an autoimmune disease characterized by chronic inflammation of the synovium, causing progressive joint destruction and reduction in quality of life for patients. Auto-antibodies in RA patients appear prior to the onset of clinic disease, and are responsible for disease progression. Our previous study showed that follicular helper T (Tfh) cells are increased in peripheral blood of RA patients and correlate with anti-citrullinated protein antibodies (ACPAs) production and disease activity score (DAS-28). IL-21 is the signature cytokine produced by Tfh cells. Through its receptor (IL-21R), IL-21 induces B cell differentiation into antibody producing plasma cells, and also promotes T cell differentiation in an autocrine manner. To dissect the role of IL-21 and IL-21R in RA, we examined the IL-21 and IL-21R expression on different subsets of B cells and T cells in RA patients and healthy donors, and determined their correlation with autoantibody level and disease activity.

Methods Peripheral blood was collected from 50 subjects (25 RA patients meeting 2010 ACR/EULAR RA classification criteria and 25 age/gender matched healthy donors). Tonsils were surgically derived from non-RA donors and used as positive controls. Clinical disease activity was assessed using DAS-28 score. RA patients were divided into four groups based on DAS-28 score ranging from remisson, low, moderate and high disease activity. Serum laboratory measurements including Rheumatoid factor (RF), ACPA, Erythrocyte sedimentation rate (ESR) and C Reactive Protein (CRP) levels were obtained. IL-21 and IL-21R expression on T cell subsets (Tfh, Th1, and Th2 cells) and B cell subsets (naïve B cell, memory B cell, and pre-plasmablast) in peripheral blood and tonsils (naïve B cells, memory B cells, germinal center B cells, and plasma cells) were determined via flow cytometry.  Pearson correlation coefficient was determined in the analysis of correlation between IL-21R expression and clinic parameters.

Results ICOS+CXCR5+ Tfh cells were identified in peripheral blood of RA patients. These circulating Tfh cells are the dominant T cell subset producing IL-21. We found that Tfh cells were significantly elevated in RA patients with moderate/high disease activity (P<0.05). IL-21R was expressed on naïve B cells, germinal center B cells, and plasma cells in tonsillar lymphoid follicles. As compared to healthy donors, the level of IL-21R expression on naïve B cells, pre-plasma cells, and T cells was significantly elevated in peripheral blood of RA patients and correlated with disease activity.

Conclusion RA patients with moderate/high disease activity have elevated levels of IL-21 expression on Tfh cells and IL-21R expression on B cell subsets, similar to that seen in tonsillar lymphoid follicles. Our results indicate that IL-21/IL-21R pathway is involved in RA pathogenesis.  Interruption of IL-21/IL-21R interaction may be a potential therapeutic target for RA patients.


Disclosure:

S. Singla,
None;

M. Chen,
None;

J. Pounds Jr.,
None;

O. Khan,
None;

J. M. Zakem,
None;

K. Collins,
None;

T. Webb-Detiege,
None;

W. E. Davis,
None;

R. Quinet,
None;

X. Zhang,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2014 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/follicular-helper-t-cells-control-autoimmunity-through-il-21il-21-receptor-interaction-in-ra-patients/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology